Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -1.37%2.99B | ---- | 6.98%5.13B | ---- | 21.87%3.03B | ---- | 56.10%4.79B | ---- | 82.42%2.49B |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -22.02%-511.26M | ---- | -25.88%-905.64M | ---- | -1.94%-418.98M | ---- | -40.32%-719.43M | ---- | -48.88%-411.03M |
| Impairment and provisions: | ---- | 490.52%57.91M | ---- | -41.89%135.96M | ---- | -113.28%-14.83M | ---- | -45.08%233.99M | ---- | 87.74%111.68M |
| -Other impairments and provisions | ---- | 52.53%-15.51M | ---- | -202.31%-44.2M | ---- | -235.64%-32.68M | ---- | -71.36%43.2M | ---- | 295.48%24.09M |
| Revaluation surplus: | ---- | 55.52%-75.74M | ---- | -1,596.07%-253.16M | ---- | -186.99%-170.27M | ---- | 33.73%-14.93M | ---- | 790.68%195.73M |
| Asset sale loss (gain): | ---- | -2,442.18%-21.79M | ---- | 31.93%-3.97M | ---- | 83.98%-857.01K | ---- | -321.53%-5.84M | ---- | -1,380.99%-5.35M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -2,442.18%-21.79M | ---- | 31.93%-3.97M | ---- | 83.98%-857.01K | ---- | -321.53%-5.84M | ---- | -1,380.99%-5.35M |
| Depreciation and amortization: | ---- | 8.38%660.9M | ---- | -4.95%1.17B | ---- | -2.68%609.78M | ---- | -10.57%1.23B | ---- | -11.05%626.59M |
| -Amortization of intangible assets | ---- | 9.50%91.93M | ---- | 7.89%176.21M | ---- | -2.67%83.96M | ---- | -31.94%163.33M | ---- | -26.88%86.26M |
| -Other depreciation and amortization | ---- | 17.27%13.26M | ---- | 65.46%25.1M | ---- | 51.29%11.31M | ---- | 20.92%15.17M | ---- | -2.23%7.47M |
| Financial expense | ---- | 165.34%51.34M | ---- | 91.32%-13.94M | ---- | 70.22%-78.57M | ---- | -36.50%-160.61M | ---- | -751.89%-263.82M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 826.13%1.31B | ---- | -312.50%-828.05M | ---- | -70.48%141.49M | ---- | -110.93%-200.74M | ---- | -68.09%479.3M |
| Accounts receivable (increase)decrease | ---- | 66.36%-1.68B | ---- | -41.51%-2.6B | ---- | 13.97%-5.01B | ---- | -179.11%-1.84B | ---- | -163.78%-5.82B |
| Accounts payable increase (decrease) | ---- | -34.16%2.64B | ---- | -56.27%3.25B | ---- | -37.58%4.01B | ---- | 684.81%7.43B | ---- | 1,505.51%6.42B |
| Special items of business | ---- | -7,997.63%-93.75M | ---- | 147.38%60.82M | ---- | 113.00%1.19M | ---- | -46.73%-128.36M | ---- | -148.30%-9.13M |
| Adjustment items of business operations | ---- | 158.04%5.42B | ---- | -52.78%5.07B | ---- | -45.07%2.1B | ---- | 160.69%10.74B | ---- | 445.01%3.82B |
| Net cash from operations | 34.06%6.98B | 153.43%5.32B | -58.30%65.08M | -51.64%5.13B | -40.15%5.21B | -44.91%2.1B | -82.40%156.05M | 163.17%10.61B | --8.7B | 429.43%3.81B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | 5.82%305.56M | ---- | 66.44%1.08B | ---- | -0.71%288.76M | ---- | 75.19%647.7M | ---- | 373.12%290.83M |
| Sale of fixed assets | ---- | 939.41%29.13M | 2,324.76%28.11M | -24.32%9.38M | -38.26%5.15M | -64.92%2.8M | --1.16M | -86.85%12.4M | -91.11%8.34M | -91.41%7.99M |
| Purchase of fixed assets | ---- | -33.16%-718.65M | -49.48%-374.29M | -41.50%-1.39B | -64.29%-1.02B | -33.20%-539.69M | ---250.39M | -11.50%-985.12M | ---618.86M | 15.17%-405.18M |
| Recovery of cash from investments | ---- | --100K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 83.55%-16.12M | ---- | 7.63%-147M | ---- | ---98M | ---- | ---159.15M | ---- | ---- |
| Other items in the investment business | ---- | -483.87%-3.22B | -36.55%-9.37B | 98.17%-165.91M | 84.39%25.62B | 118.72%839.19M | -975.53%-6.86B | -305.79%-9.07B | --13.89B | -349.64%-4.48B |
| Net cash from investment operations | ---- | -834.48%-3.62B | ---- | 93.52%-619.44M | 85.94%-1.25B | 110.75%493.05M | ---- | -267.93%-9.56B | ---8.86B | -402.59%-4.59B |
| Net cash before financing | ---- | -34.41%1.7B | ---- | 327.98%4.51B | ---- | 433.89%2.59B | ---- | -26.51%1.05B | ---- | -134.73%-776.62M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 582.29%2.22B | 162.31%1.08B | -18.03%2.22B | ---- | -82.24%325.35M | -49.59%412.62M | 83.10%2.71B | ---- | 193.37%1.83B |
| Refund | ---- | -590.98%-1.68B | -140.65%-841.79M | -9.62%-1.76B | -145.31%-1.32B | 30.38%-243.58M | ---349.8M | 43.58%-1.61B | 77.58%-538.12M | 80.43%-349.87M |
| Dividends paid - financing | ---- | -13.93%-1.53B | 49.54%-71.59M | -129.43%-4.39B | -82.17%-3.42B | -18.24%-1.34B | 70.51%-141.87M | -7.83%-1.91B | ---1.88B | -88.88%-1.13B |
| Absorb investment income | ---- | ---- | ---- | -97.81%5M | ---- | -97.19%5M | ---- | --228.14M | ---- | --178.18M |
| Other items of the financing business | ---- | 123.83%323.64M | 125.02%117.42M | -3,405.91%-1.19B | -4,129.77%-1.49B | -423.87%-1.36B | -10.32%-469.35M | -102.49%-34M | 92.01%-35.27M | -20.71%419.29M |
| Net cash from financing operations | ---- | 74.42%-668.29M | ---- | -724.51%-5.12B | -2,374.45%-4.52B | -376.52%-2.61B | ---- | 65.08%-621.14M | ---182.62M | 176.49%944.94M |
| Effect of rate | ---- | 140.37%43.38M | ---- | -124.12%-77.28M | ---- | -265.14%-107.47M | ---- | 39.44%-34.48M | ---- | 55.37%-29.43M |
| Net Cash | ---- | 5,272.95%1.03B | ---- | -240.46%-608.59M | -52.66%-612.76M | -111.86%-19.96M | ---- | 225.99%433.28M | ---401.4M | -83.19%168.32M |
| Begining period cash | ---- | -23.84%2.19B | ---- | 16.09%2.88B | ---- | 16.09%2.88B | ---- | -13.92%2.48B | ---- | -13.92%2.48B |
| Cash at the end | ---- | 18.81%3.27B | ---- | -23.84%2.19B | ---- | 5.06%2.75B | ---- | 16.09%2.88B | ---- | -31.38%2.62B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.